NEW YORK (GenomeWeb News) - Ariana Pharma, a Paris-based provider of drug discovery software tools, said today that it has raised €1.5 million ($2.3 million) through a private placement.
 
Vizille Capital Innovation, a subsidiary of the Crédit Mutuel - CIC bank, was the sole investor in the round and gained a minority stake in the firm. VCI joins Ariana's existing shareholders, the Pasteur Institute and company management.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.